GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Change In Receivables

Beijing Tiantan Biological Products (SHSE:600161) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Change In Receivables?

Beijing Tiantan Biological Products's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Beijing Tiantan Biological Products's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Beijing Tiantan Biological Products's change in receivables for the fiscal year that ended in Dec. 2024 was ¥-473 Mil. It means Beijing Tiantan Biological Products's Accounts Receivable increased by ¥473 Mil from Dec. 2023 to Dec. 2024 .

Beijing Tiantan Biological Products's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥586 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beijing Tiantan Biological Products's Days Sales Outstanding for the three months ended in Mar. 2025 was 40.59.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beijing Tiantan Biological Products's liquidation value for the three months ended in Mar. 2025 was ¥3,351 Mil.


Beijing Tiantan Biological Products Change In Receivables Historical Data

The historical data trend for Beijing Tiantan Biological Products's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Change In Receivables Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -82.48 -351.21 -221.05 1,029.48 -473.12

Beijing Tiantan Biological Products Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Beijing Tiantan Biological Products Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Tiantan Biological Products  (SHSE:600161) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beijing Tiantan Biological Products's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=586.208/1317.766*91
=40.59

2. In Ben Graham's calculation of liquidation value, Beijing Tiantan Biological Products's accounts receivable are only considered to be worth 75% of book value:

Beijing Tiantan Biological Products's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2280.717-1364.862+0.75 * 586.208+0.5 * 3990.385
=3,351

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Tiantan Biological Products Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Boxing 2nd Road, Room 521, Building 8, Beijing Economic and Technological Development Zone, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business.
Executives
Zhang Yi senior management
Ci Xiang senior management
Fu Dao Xing Directors, senior managers
Hu Li Gang Director
Yang Hui Chuan Director
Liu Ya Na Directors, senior managers
He Yan Lin Directors, senior managers
Wang Jian Ming Supervisors
Wu Zhen Shan senior management

Beijing Tiantan Biological Products Headlines

No Headlines